What to expect in the Adaptive Biotechnologies Corp interview process

Based on publicly available sources, Adaptive Biotechnologies Corp. is a Seattle-headquartered pioneer in immune-driven medicine founded in 2009, operating with approximately 531 to 669 employees across a global footprint spanning 7 countries, including the United States, Germany, Canada, Nigeria, and India. The company maintains a market cap of $1.3B, annual revenue of $277M, and went public via an IPO in 2019.

Workforce data indicates some headcount volatility, with total global employees shifting from 777 in 2023 down to roughly 632–669 in 2026. Despite past contractions, hiring activity has picked up, showing an active increase in job postings. The company operates physical workspaces across three offices, including its headquarters in Seattle (1165 Eastlake Ave E) and a location in South San Francisco.

Public insights highlight that Adaptive relies on an advanced tech stack including Cerner, Azure Databricks, and Kubernetes to support its data workflows. In terms of workplace recognition, the company was awarded Workplace of the Year by GeekWire in 2023 for its innovative and inclusive environment. Feedback regarding leadership and management indicates a mix of strategic vision, decisive portfolio moves, and delivery on major milestones alongside operational challenges.